Medical Weight Loss for St. Petersburg, Florida Residents

St. Petersburg, Florida residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving St. Petersburg through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Open to all of Florida, including St. Petersburg: our Costa Mesa, California physicians treat patients statewide by telehealth, so distance from our office never changes the care you receive. Doctor review just $119 (medication separate).

Why St. Petersburg Residents Choose New Hope Weight Loss

We made New Hope easy to start without making it less serious. A St. Petersburg patient can go from first visit to a physician-approved plan without insurance paperwork, prior authorizations, or a single drive to an office. The $119 review with Dr. Anjmun Sharma is flat, the medication price is published, and the whole thing happens by telehealth. Low friction to begin, real medicine once you do, the same standard everyone in Florida gets.

St. Petersburg and the greater Tampa Bay area are served through telehealth from our Costa Mesa, California clinic. The full physician-supervised program runs by secure video, with compounded medication shipped to your St. Petersburg address.

You do not need a clinic on your street in St. Petersburg to work with a real physician, because everything Dr. Sharma offers from Costa Mesa reaches patients across Florida by secure telehealth. We care for patients throughout Downtown, the Old Northeast, Kenwood, the Beaches, and the greater Tampa Bay area. There is no distance surcharge for living outside Costa Mesa, and we accept HSA, FSA, Klarna, and Affirm to make starting easier across Florida.

Because your care happens by telehealth, there is no waitlist to clear and most St. Petersburg patients can have their physician visit scheduled within the same week. Between Klarna, Affirm, and HSA or FSA cards, St. Petersburg patients have several ways to handle the $119 review and ongoing medication payments. Florida is one of the most populous states in the nation, and New Hope Weight Loss serves patients across it entirely by telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Two GLP-1 paths, one plan built around you

The 90-Day Metabolic Reset uses semaglutide, the same active ingredient in Wegovy and Ozempic. From $166 a month, or $499 for the full 90 days, it pairs medication with monthly check-ins. Branded-drug trials showed average loss of about 15 to 17 percent. Compounded semaglutide is not FDA-approved and not brand-identical, and results vary from person to person.

Want a stronger option? Ask about tirzepatide

From $233 a month, tirzepatide combines GLP-1 and GIP action. Trial participants on qualifying doses saw up to 22.5 percent body-weight loss, a top-dose number rather than the average. It carries the same active ingredient as Mounjaro and Zepbound.

Your $119 physician review comes first. Medication is billed separately. HSA, FSA, Klarna, and Affirm are all welcome for St. Petersburg patients.

How Telehealth Works for St. Petersburg

Step 1. Complete the online intake and weight-history quiz from your phone or laptop.

Step 2. Dr. Sharma reviews everything and meets you over secure video, typically within 48 hours, to confirm whether compounded semaglutide or tirzepatide makes sense for you.

Step 3. If appropriate, a state-licensed 503(a) pharmacy ships your medication to your St. Petersburg home in insulated cold-pack packaging.

Step 4. You check in by video for follow-ups, so adjusting your dose never means a drive across .

Frequently Asked Questions, St. Petersburg

Does New Hope Weight Loss have a presence in St. Petersburg?

Our presence in St. Petersburg is through telehealth rather than a storefront. The clinic itself is in Costa Mesa, California, our sole physical location. We serve St. Petersburg, Florida patients online, and Dr. Anjmun Sharma confirms your eligibility for compounded semaglutide or tirzepatide during a private video consultation.

Could a St. Petersburg patient complete care without leaving home?

Yes, staying home is the norm. Everything for St. Petersburg patients runs over telehealth, including the initial consult, dose adjustments, and check-ins. After approval, your medication travels to St. Petersburg in insulated cold-pack shipping that protects it from temperature swings during delivery.

How are St. Petersburg patients charged?

There is a $119 fee for the physician review. Semaglutide starts at $166 monthly, with a 90-day option at $499, and tirzepatide at $233 monthly. The medication itself is a separate cost. We accept HSA, FSA, Klarna, and Affirm, and we add no distance surcharge for St. Petersburg.

What areas of St. Petersburg do you serve?

We serve patients from across St. Petersburg by telehealth, including Downtown, the Old Northeast, Kenwood, the Beaches, and the greater Tampa Bay area.

Can St. Petersburg patients use an HSA or FSA to pay?

Yes. The $119 physician visit and the program are HSA- and FSA-eligible, and Klarna and Affirm financing are accepted. Pricing is flat and stated up front, with medication billed separately, and there is no distance surcharge for St. Petersburg patients.

St. Petersburg Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving St. Petersburg, Florida by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.